Analytical and Bioanalytical Chemistry

, Volume 406, Issue 12, pp 2957–2964 | Cite as

Conjugation-free, visual, and quantitative evaluation of inhibitors on protein tyrosine kinases and phosphatases with a luminescent Tb(III) complex

  • Hiroki Akiba
  • Jun SumaokaEmail author
  • Takao Hamakubo
  • Makoto KomiyamaEmail author
Research Paper


A straightforward and visual method to assess inhibitors on protein tyrosine kinases (PTKs) and phosphatases (PTPs) has been developed. These enzymes play critical roles in a number of diseases and, thus, their inhibitors are important for effective therapy. With the use of the long-life luminescence emitted from a binuclear Tb(III) complex, enzymatic reactions of PTKs and PTPs were monitored in real-time, and the inhibitor activity was quantitatively evaluated in terms of the decrease in the rate of luminescence change. No conjugation of the probe to a substrate peptide was necessary. The IC50 values of four inhibitors on three kinds of PTKs [Src, Fyn, and epidermal growth factor receptor (EGFR)] were determined. For example, gefitinib, which is a selective inhibitor on EGFR, inhibited this PTK with IC50 of 22 nM. Towards Src and Fyn (non-targeted PTK), however, IC50 of this inhibitor was greater than 20 μM as expected. Inhibition of two kinds of PTPs (Shp-1 and PTP1B) by two inhibitors was also assayed, providing completely consistent results on their known selectivity. Furthermore, the system where both PTK and PTP are active was monitored and the reactions were visualized with the present Tb(III) complex-based method. High potential of the present method to a variety of systems has been evidenced.


Bioanalytical methods Fluorescence Luminescence Chemical sensors Enzymes Rare earth elements Pharmaceuticals 



This work was supported by Grant-in-Aid for Scientific Research (23510276 to J.S.) from Ministry of Education, Culture, Sports, Science, and Technology, Japan. H.A. was supported as a JSPS Research Fellow.

Supplementary material

216_2014_7707_MOESM1_ESM.pdf (345 kb)
ESM 1 (PDF 345 kb)


  1. 1.
    Cohen P, Alessi DR (2013) Kinase drug discovery—what’s next in the field? ACS Chem Biol 8:96–104CrossRefGoogle Scholar
  2. 2.
    De Munter S, Köhn M, Bollen M (2013) Challenges and opportunities in the development of protein phosphatase-directed therapeutics. ACS Chem Biol 8:36–45CrossRefGoogle Scholar
  3. 3.
    Lu CHS, Liu K, Tan LP, Yao SQ (2012) Current chemical biology tools for studying protein phosphorylation and dephosphorylation. Chem Eur J 18:28–39CrossRefGoogle Scholar
  4. 4.
    González-Vera JA (2012) Probing the kinome in real time with fluorescent peptides. Chem Soc Rev 41:1652–1664CrossRefGoogle Scholar
  5. 5.
    Mitra S, Barrios AM (2005) Highly sensitive peptide-based probes for protein tyrosine phosphatase activity utilizing a fluorogenic mimic of phosphotyrosine. Bioorg Med Chem Lett 15:5142–5145CrossRefGoogle Scholar
  6. 6.
    Kawaguchi M, Hanaoka K, Komatsu T et al (2011) Development of a highly selective fluorescence probe for alkaline phosphatase. Bioorg Med Chem Lett 21:5088–5091CrossRefGoogle Scholar
  7. 7.
    Kurishita Y, Kohira T, Ojida A, Hamachi I (2010) Rational design of FRET-based ratiometric chemosensors for in vitro and in cell fluorescence analyses of nucleoside polyphosphates. J Am Chem Soc 132:13290–13299CrossRefGoogle Scholar
  8. 8.
    Hong L, Quinn CM, Jia Y (2009) Evaluating the utility of the HTRF Transcreener ADP assay technology: a comparison with the standard HTRF assay technology. Anal Biochem 391:31–38CrossRefGoogle Scholar
  9. 9.
    Geladopoulos TP, Sotiroudis TG, Evangelopoulos AE (1991) A malachite green colorimetric assay for protein phosphatase activity. Anal Biochem 192:112–116CrossRefGoogle Scholar
  10. 10.
    Ojida A, Mito-oka Y, Sada K, Hamachi I (2004) Molecular recognition and fluorescence sensing of monophosphorylated peptides in aqueous solution by bis(zinc(II)-dipicolylamine)-based artificial receptors. J Am Chem Soc 126:2454–2463CrossRefGoogle Scholar
  11. 11.
    Bünzli J-CG (2010) Lanthanide luminescence for biomedical analyses and imaging. Chem Rev 110:2729–2755CrossRefGoogle Scholar
  12. 12.
    Butler SJ, Parker D (2013) Anion binding in water at lanthanide centres: from structure and selectivity to signalling and sensing. Chem Soc Rev 42:1652–1666CrossRefGoogle Scholar
  13. 13.
    Appelblom H, Sipponen A, Valanne A et al (2011) Antibody-free lanthanide-based fluorescent probe for determination of protein tyrosine kinase and phosphatase activities. Microchim Acta 172:25–29CrossRefGoogle Scholar
  14. 14.
    Atkinson P, Murray BS, Parker D (2006) A cationic lanthanide complex binds selectively to phosphorylated tyrosine sites, aiding NMR analysis of the phosphorylated insulin receptor peptide fragment. Org Biomol Chem 4:3166–3171CrossRefGoogle Scholar
  15. 15.
    Liu LL, Franz KJ (2005) Phosphorylation of an alpha-synuclein peptide fragment enhances metal binding. J Am Chem Soc 127:9662–9663CrossRefGoogle Scholar
  16. 16.
    Pazos E, Goličnik M, Mascareñas JL, Vázquez ME (2012) Detection of phosphorylation states by intermolecular sensitization of lanthanide-peptide conjugates. Chem Commun 48:9534–9536CrossRefGoogle Scholar
  17. 17.
    Tremblay MS, Lee M, Sames D (2008) A luminescent sensor for tyrosine phosphorylation. Org Lett 10:5–8CrossRefGoogle Scholar
  18. 18.
    Zondlo SC, Gao F, Zondlo NJ (2010) Design of an encodable tyrosine kinase-inducible domain: detection of tyrosine kinase activity by terbium luminescence. J Am Chem Soc 132:5619–5621CrossRefGoogle Scholar
  19. 19.
    Lipchik AM, Parker LL (2013) Time-resolved luminescence detection of spleen tyrosine kinase activity through terbium sensitization. Anal Chem 85:2582–2588CrossRefGoogle Scholar
  20. 20.
    Akiba H, Sumaoka J, Komiyama M (2009) Selective detection of phosphotyrosine in the presence of various phosphate-containing biomolecules with the aid of a terbium(III) complex. ChemBioChem 10:1773–1776CrossRefGoogle Scholar
  21. 21.
    Akiba H, Sumaoka J, Komiyama M (2010) Binuclear terbium(III) complex as a probe for tyrosine phosphorylation. Chem Eur J 16:5018–5025CrossRefGoogle Scholar
  22. 22.
    Songyang Z, Carraway KL, Eck MJ et al (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536–539CrossRefGoogle Scholar
  23. 23.
    Parsons SJ, Parsons JT (2004) Src family kinases, key regulators of signal transduction. Oncogene 23:7906–7909CrossRefGoogle Scholar
  24. 24.
    Karaman MW, Herrgard S, Treiber DK et al (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26:127–132CrossRefGoogle Scholar
  25. 25.
    Ross JS, Schenkein DP, Pietrusko R et al (2004) Targeted Therapies for Cancer 2004. Am J Clin Pathol 122:598–609CrossRefGoogle Scholar
  26. 26.
    Capdeville R, Buchdunger E, Zimmermann J, Matter A (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1:493–502CrossRefGoogle Scholar
  27. 27.
    Ciardiello F, Tortora G (2008) EGFR antagonists in cancer treatment. N Engl J Med 358:1160–1174CrossRefGoogle Scholar
  28. 28.
    Anastassiadis T, Deacon SW, Devarajan K et al (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29:1039–1045CrossRefGoogle Scholar
  29. 29.
    Simard JR, Klüter S, Grütter C et al (2009) A new screening assay for allosteric inhibitors of cSrc. Nat Chem Biol 5:394–396CrossRefGoogle Scholar
  30. 30.
    Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 % inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108CrossRefGoogle Scholar
  31. 31.
    Hemmila I (1999) LANCE™: homogeneous assay platform for HTS. J Biomol Screen 4:303–307CrossRefGoogle Scholar
  32. 32.
    Tiganis T, Bennett AM (2007) Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402:1–415Google Scholar
  33. 33.
    Arabaci G, Guo X-C, Beebe KD et al (1999) α-Haloacetophenone derivatives as photoreversible covalent inhibitors of protein tyrosine phosphatases. J Am Chem Soc 121:5085–5086CrossRefGoogle Scholar
  34. 34.
    Gordon JA (1991) Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol 201:477–482CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Research Center for Advanced Science and TechnologyThe University of TokyoTokyoJapan
  2. 2.Life Science Center of Tsukuba Advanced Research AllianceUniversity of TsukubaTsukubaJapan

Personalised recommendations